Tilray Brands has recently announced the publication of a new scientific study supported by Tilray Medical that delves into the real-world effects of cannabinoid treatments on fibromyalgia patients under the supervision of healthcare professionals.

For more information about the study, you can access the full story through this link.

In addition, here are some of the top cannabis news stories from this past week:
– Cresco Labs has disclosed the retirement of Dennis Olis as their chief financial officer.
– Aurora Cannabis and Vectura Fertin Pharma have jointly launched a novel Luo CBD lozenge.
– Tinley has successfully closed a non-brokered private placement, raising gross proceeds totaling $1.8 million.

Furthermore, here are the top cannabis stocks from September 6th to September 12th, 2024, based on views:
1. T.TLRY – Tilray Brands Inc.
2. T.WEED – Canopy Growth Corp.
3. C.CURA – Curaleaf Holdings Inc.
4. T.LABS – Medipharm Labs Corp.
5. C.OILS – Nextleaf Solutions Ltd.
6. T.OGI – OrganiGram Holdings Inc.

Please note that the information provided in this article is for informational purposes only and should not be construed as investment advice. For the full disclaimer, please refer to this link.

Share.

Alexander is the founder and author of Microcaps.ca, a leading resource for investors interested in the micro-cap stock market. With a passion for uncovering hidden gems in the world of small-cap stocks, Alexander combines in-depth research with years of experience in the financial markets to provide readers with valuable insights and timely analysis. Investors should conduct their own research or consult with a qualified investment advisor before making any investment decisions. The author of this article is not responsible for any gains or losses incurred from investing in companies mentioned.

Leave A Reply

Exit mobile version